Other Species / Isoforms
  EB1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
Y6-p
__MAVNVysTsVTSD
0 1
EB1 (human) __MAVNVysTsVTSD Y6-p
EB1 (mouse) __MAVNVYSTSVTSD Y6
EB1 (rat) __MAVNVYSTSVTSD Y6
S7-p
_MAVNVysTsVTSDN
0 1
EB1 (human) _MAVNVysTsVTSDN S7-p
EB1 (mouse) _MAVNVYSTSVTSDN S7
EB1 (rat) _MAVNVYSTSVTSDN S7
S9-p
AVNVysTsVTSDNLS
0 1
EB1 (human) AVNVysTsVTSDNLS S9-p
EB1 (mouse) AVNVYSTSVTSDNLS S9
EB1 (rat) AVNVYSTSVTSDNLS S9
S40-p
TKIEQLCsGAAYCQF
Upstream
Downstream
2 1
Effects on Modified Protein
  • molecular association, regulation
  • protein conformation
Effects on Biological Processes:
  • cytoskeletal reorganization
Kinase, in vitro:
  • ASK1 (human)
Putative in vivo kinases:
  • ASK1 (human)
EB1 (human) TKIEQLCsGAAYCQF S40-p
EB1 (mouse) TKIEQLCSGAAYCQF S40
EB1 (rat) TKIEQLCSGAAYCQF S40
K60-ac
PGSIALKkVKFQAkL
0 2
EB1 (human) PGSIALKkVKFQAkL K60-ac
EB1 (mouse) PGSIALKKVKFQAKL K60
EB1 (rat) PGSIALKKVKFQAKL K60
K66-ac
KkVKFQAkLEHEyIQ
0 1
EB1 (human) KkVKFQAkLEHEyIQ K66-ac
EB1 (mouse) KKVKFQAKLEHEYIQ K66
EB1 (rat) KKVKFQAKLEHEYIQ K66
K66-ub
KkVKFQAkLEHEyIQ
0 4
EB1 (human) KkVKFQAkLEHEyIQ K66-ub
EB1 (mouse) KKVKFQAKLEHEYIQ K66
EB1 (rat) KKVKFQAKLEHEYIQ K66
Y71-p
QAkLEHEyIQNFkIL
0 1
EB1 (human) QAkLEHEyIQNFkIL Y71-p
EB1 (mouse) QAKLEHEYIQNFKIL Y71
EB1 (rat) QAKLEHEYIQNFKIL Y71
K76-ub
HEyIQNFkILQAGFk
0 4
EB1 (human) HEyIQNFkILQAGFk K76-ub
EB1 (mouse) HEYIQNFKILQAGFk K76
EB1 (rat) HEYIQNFKILQAGFk K76
K76-ac
HEyIQNFkILQAGFk
0 5
EB1 (human) HEyIQNFkILQAGFk K76-ac
EB1 (mouse) HEYIQNFKILQAGFk K76
EB1 (rat) HEYIQNFKILQAGFk K76
K83-ac
kILQAGFkRMGVDkI
0 14
EB1 (human) kILQAGFkRMGVDkI K83-ac
EB1 (mouse) KILQAGFkRMGVDKI K83-ac
EB1 (rat) KILQAGFkRMGVDKI K83-ac
K83-ub
kILQAGFkRMGVDkI
0 7
EB1 (human) kILQAGFkRMGVDkI K83-ub
EB1 (mouse) KILQAGFKRMGVDKI K83
EB1 (rat) KILQAGFKRMGVDKI K83
K83-sc
kILQAGFkRMGVDkI
0 1
EB1 (human) kILQAGFkRMGVDkI K83-sc
EB1 (mouse) KILQAGFkRMGVDKI K83-sc
EB1 (rat) KILQAGFKRMGVDKI K83
K89-ac
FkRMGVDkIIPVDkL
0 1
EB1 (human) FkRMGVDkIIPVDkL K89-ac
EB1 (mouse) FkRMGVDKIIPVDKL K89
EB1 (rat) FkRMGVDKIIPVDkL K89
K95
DkIIPVDKLVKGkFQ
0 1
EB1 (human) DkIIPVDKLVKGkFQ K95
EB1 (mouse) DKIIPVDKLVKGkFQ K95
EB1 (rat) DKIIPVDkLVKGKFQ K95-ac
K95-ub
DkIIPVDkLVKGkFQ
0 2
EB1 (human) DkIIPVDkLVKGkFQ K95-ub
EB1 (mouse) DKIIPVDKLVKGkFQ K95
EB1 (rat) DKIIPVDKLVKGKFQ K95
K100-ub
VDkLVKGkFQDNFEF
0 2
EB1 (human) VDkLVKGkFQDNFEF K100-ub
EB1 (mouse) VDKLVKGkFQDNFEF K100-ub
EB1 (rat) VDkLVKGKFQDNFEF K100
Y119-p
KKFFDANyDGkDyDP
0 3
EB1 (human) KKFFDANyDGkDyDP Y119-p
EB1 (mouse) KKFFDANYDGKEYDP Y119
EB1 (rat) KKFFDANYDGKEYDP Y119
K122-ub
FDANyDGkDyDPVAA
0 3
EB1 (human) FDANyDGkDyDPVAA K122-ub
EB1 (mouse) FDANYDGKEYDPVAA K122
EB1 (rat) FDANYDGKEYDPVAA K122
Y124-p
ANyDGkDyDPVAARQ
0 262
EB1 (human) ANyDGkDyDPVAARQ Y124-p
EB1 (mouse) ANYDGKEYDPVAARQ Y124
EB1 (rat) ANYDGKEYDPVAARQ Y124
S140-p
QETAVAPsLVAPALN
0 1
EB1 (human) QETAVAPsLVAPALN S140-p
EB1 (mouse) QETAVAPSLVAPALs S140
EB1 (rat) QETAVAPSLVAPALS S140
N147
sLVAPALNkPkkPLt
0 1
EB1 (human) sLVAPALNkPkkPLt N147
EB1 (mouse) SLVAPALskPkKPLG S147-p
EB1 (rat) SLVAPALSKPKKPLG S147
K148-ub
LVAPALNkPkkPLts
0 12
EB1 (human) LVAPALNkPkkPLts K148-ub
EB1 (mouse) LVAPALskPkKPLGs K148-ub
EB1 (rat) LVAPALSKPKKPLGS K148
K150-ub
APALNkPkkPLtssS
0 10
EB1 (human) APALNkPkkPLtssS K150-ub
EB1 (mouse) APALskPkKPLGsST K150-ub
EB1 (rat) APALSKPKKPLGSGS K150
K151-ub
PALNkPkkPLtssSA
0 4
EB1 (human) PALNkPkkPLtssSA K151-ub
EB1 (mouse) PALskPkKPLGsSTA K151
EB1 (rat) PALSKPKKPLGSGSA K151
K151-m1
PALNkPkkPLtssSA
0 1
EB1 (human) PALNkPkkPLtssSA K151-m1
EB1 (mouse) PALskPkKPLGsSTA K151
EB1 (rat) PALSKPKKPLGSGSA K151
T154-p
NkPkkPLtssSAAPQ
Upstream
Downstream
2 2
Effects on Modified Protein
  • molecular association, regulation
  • protein conformation
Effects on Biological Processes:
  • cytoskeletal reorganization
Kinase, in vitro:
  • ASK1 (human)
Putative in vivo kinases:
  • ASK1 (human)
EB1 (human) NkPkkPLtssSAAPQ T154-p
EB1 (mouse) skPkKPLGsSTAAPQ G154
EB1 (rat) SKPKKPLGSGSAAPQ G154
S155-p
kPkkPLtssSAAPQR
Upstream
Downstream
2 10
Effects on Modified Protein
  • intracellular localization
Effects on Biological Processes:
  • apoptosis, inhibited
  • carcinogenesis, induced
  • carcinogenesis, inhibited
  • cell growth, induced
  • cell motility, induced
  • cell motility, inhibited
  • cytoskeletal reorganization
  • signaling pathway regulation
Putative in vivo kinases:
  • GSK3B (human)
Treatment
  • JAK_inhibitor_I
  • MEK_inhibitor_I
  • SB216763
EB1 (human) kPkkPLtssSAAPQR S155-p
EB1 (mouse) kPkKPLGsSTAAPQR S155-p
EB1 (rat) KPKKPLGSGSAAPQR S155
S156-p
PkkPLtssSAAPQRP
Upstream
Downstream
1 0
Effects on Modified Protein
  • intracellular localization
Effects on Biological Processes:
  • carcinogenesis, inhibited
  • cell motility, inhibited
  • cytoskeletal reorganization
  • signaling pathway regulation
Putative in vivo kinases:
  • GSK3B (human)
Treatment
  • SB216763
EB1 (human) PkkPLtssSAAPQRP S156-p
EB1 (mouse) PkKPLGsSTAAPQRP S156
EB1 (rat) PKKPLGSGSAAPQRP G156
S165-p
AAPQRPIstQRTAAA
0 5
EB1 (human) AAPQRPIstQRTAAA S165-p
EB1 (mouse) AAPQRPIAtQRTTAA A165
EB1 (rat) AAPQRPIATQRTTAA A165
T166-p
APQRPIstQRTAAAP
Downstream
1 4
Effects on Modified Protein
  • intracellular localization
Effects on Biological Processes:
  • apoptosis, induced
  • carcinogenesis, inhibited
  • cell growth, inhibited
  • cell motility, inhibited
  • cytoskeletal reorganization
EB1 (human) APQRPIstQRTAAAP T166-p
EB1 (mouse) APQRPIAtQRTTAAP T166-p
EB1 (rat) APQRPIATQRTTAAP T166
K174-ub
QRTAAAPkAGPGVVR
0 4
EB1 (human) QRTAAAPkAGPGVVR K174-ub
EB1 (mouse) QRTTAAPkAGPGMVR K174-ub
EB1 (rat) QRTTAAPKAGPGMVR K174
K182-ub
AGPGVVRkNPGVGNG
0 3
EB1 (human) AGPGVVRkNPGVGNG K182-ub
EB1 (mouse) AGPGMVRkNPGVGNG K182-ub
EB1 (rat) AGPGMVRKNPGMGNG K182
T206-p
QVNVLKLtVEDLEkE
Upstream
Downstream
3 1
Effects on Modified Protein
  • molecular association, regulation
  • protein conformation
Effects on Biological Processes:
  • cytoskeletal reorganization
Kinase, in vitro:
  • ASK1 (human)
Putative in vivo kinases:
  • ASK1 (human)
EB1 (human) QVNVLKLtVEDLEkE T206-p
EB1 (mouse) QVKVLKLTVEDLEKE T206
EB1 (rat) QVKVLKLTVEDLEKE T206
K212-ub
LtVEDLEkERDFyFG
0 2
EB1 (human) LtVEDLEkERDFyFG K212-ub
EB1 (mouse) LTVEDLEKERDFYFG K212
EB1 (rat) LTVEDLEKERDFYFG K212
K212-sm
LtVEDLEkERDFyFG
0 1
EB1 (human) LtVEDLEkERDFyFG K212-sm
EB1 (mouse) LTVEDLEKERDFYFG K212
EB1 (rat) LTVEDLEKERDFYFG K212
Y217-p
LEkERDFyFGkLRNI
1 1
EB1 (human) LEkERDFyFGkLRNI Y217-p
EB1 (mouse) LEKERDFYFGkLRNI Y217
EB1 (rat) LEKERDFYFGKLRNI Y217
K220-ac
ERDFyFGkLRNIELI
Upstream
Downstream
1 2
Effects on Modified Protein
  • molecular association, regulation
  • protein conformation
Effects on Biological Processes:
  • cell cycle regulation
  • cytoskeletal reorganization
Treatment
  • siRNA
EB1 (human) ERDFyFGkLRNIELI K220-ac
EB1 (mouse) ERDFYFGKLRNIELI K220
EB1 (rat) ERDFYFGKLRNIELI K220
K220-ub
ERDFyFGkLRNIELI
Upstream
0 23
Treatment
  • MG132
EB1 (human) ERDFyFGkLRNIELI K220-ub
EB1 (mouse) ERDFYFGkLRNIELI K220-ub
EB1 (rat) ERDFYFGKLRNIELI K220
Y247-p
QRIVDILyATDEGFV
Upstream
Downstream
3 1
Effects on Modified Protein
  • intracellular localization
  • molecular association, regulation
  • phosphorylation
  • protein conformation
Effects on Biological Processes:
  • cell adhesion, altered
  • cell cycle regulation
  • cell motility, induced
  • cytoskeletal reorganization
  • signaling pathway regulation
  • transcription, induced
Kinase, in vitro:
  • Src (human)
Putative in vivo kinases:
  • Src (human)
Putative upstream phosphatases:
  • PTPN22 (human)
Treatment
  • siRNA
EB1 (human) QRIVDILyATDEGFV Y247-p
EB1 (mouse) QRIVDILYATDEGFV Y247
EB1 (rat) QRIVDILYATDEGFV Y247
Y268-p
PQEEQEEy_______
0 2
EB1 (human) PQEEQEEy_______ Y268-p
EB1 (mouse) PQEEQEEY_______ Y268
EB1 (rat) PQEEQEEY_______ Y268